Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Nov 1;100(9):2146–2152. doi: 10.1172/JCI119750

Nitric oxide synthases: which, where, how, and why?

T Michel 1, O Feron 1
PMCID: PMC508408  PMID: 9410890

Full Text

The Full Text of this article is available as a PDF (265.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ames J. B., Ishima R., Tanaka T., Gordon J. I., Stryer L., Ikura M. Molecular mechanics of calcium-myristoyl switches. Nature. 1997 Sep 11;389(6647):198–202. doi: 10.1038/38310. [DOI] [PubMed] [Google Scholar]
  2. Anderson R. G. Caveolae: where incoming and outgoing messengers meet. Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):10909–10913. doi: 10.1073/pnas.90.23.10909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ayajiki K., Kindermann M., Hecker M., Fleming I., Busse R. Intracellular pH and tyrosine phosphorylation but not calcium determine shear stress-induced nitric oxide production in native endothelial cells. Circ Res. 1996 May;78(5):750–758. doi: 10.1161/01.res.78.5.750. [DOI] [PubMed] [Google Scholar]
  4. Bates T. E., Loesch A., Burnstock G., Clark J. B. Mitochondrial nitric oxide synthase: a ubiquitous regulator of oxidative phosphorylation? Biochem Biophys Res Commun. 1996 Jan 5;218(1):40–44. doi: 10.1006/bbrc.1996.0008. [DOI] [PubMed] [Google Scholar]
  5. Bickel P. E., Scherer P. E., Schnitzer J. E., Oh P., Lisanti M. P., Lodish H. F. Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins. J Biol Chem. 1997 May 23;272(21):13793–13802. doi: 10.1074/jbc.272.21.13793. [DOI] [PubMed] [Google Scholar]
  6. Brenman J. E., Chao D. S., Gee S. H., McGee A. W., Craven S. E., Santillano D. R., Wu Z., Huang F., Xia H., Peters M. F. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains. Cell. 1996 Mar 8;84(5):757–767. doi: 10.1016/s0092-8674(00)81053-3. [DOI] [PubMed] [Google Scholar]
  7. Brenman J. E., Chao D. S., Xia H., Aldape K., Bredt D. S. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell. 1995 Sep 8;82(5):743–752. doi: 10.1016/0092-8674(95)90471-9. [DOI] [PubMed] [Google Scholar]
  8. Buchwalow I. B., Schulze W., Kostic M. M., Wallukat G., Morwinski R. Intracellular localization of inducible nitric oxide synthase in neonatal rat cardiomyocytes in culture. Acta Histochem. 1997 Jun;99(2):231–240. doi: 10.1016/S0065-1281(97)80046-3. [DOI] [PubMed] [Google Scholar]
  9. Corson M. A., James N. L., Latta S. E., Nerem R. M., Berk B. C., Harrison D. G. Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ Res. 1996 Nov;79(5):984–991. doi: 10.1161/01.res.79.5.984. [DOI] [PubMed] [Google Scholar]
  10. Couet J., Li S., Okamoto T., Ikezu T., Lisanti M. P. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem. 1997 Mar 7;272(10):6525–6533. doi: 10.1074/jbc.272.10.6525. [DOI] [PubMed] [Google Scholar]
  11. Feron O., Belhassen L., Kobzik L., Smith T. W., Kelly R. A., Michel T. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem. 1996 Sep 13;271(37):22810–22814. doi: 10.1074/jbc.271.37.22810. [DOI] [PubMed] [Google Scholar]
  12. Feron O., Smith T. W., Michel T., Kelly R. A. Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes. J Biol Chem. 1997 Jul 11;272(28):17744–17748. doi: 10.1074/jbc.272.28.17744. [DOI] [PubMed] [Google Scholar]
  13. Guo F. H., De Raeve H. R., Rice T. W., Stuehr D. J., Thunnissen F. B., Erzurum S. C. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7809–7813. doi: 10.1073/pnas.92.17.7809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Harrison D. G. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest. 1997 Nov 1;100(9):2153–2157. doi: 10.1172/JCI119751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ignarro L. J. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol. 1990;30:535–560. doi: 10.1146/annurev.pa.30.040190.002535. [DOI] [PubMed] [Google Scholar]
  16. Jaffrey S. R., Snyder S. H. PIN: an associated protein inhibitor of neuronal nitric oxide synthase. Science. 1996 Nov 1;274(5288):774–777. doi: 10.1126/science.274.5288.774. [DOI] [PubMed] [Google Scholar]
  17. Ju H., Zou R., Venema V. J., Venema R. C. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J Biol Chem. 1997 Jul 25;272(30):18522–18525. doi: 10.1074/jbc.272.30.18522. [DOI] [PubMed] [Google Scholar]
  18. Li S., Couet J., Lisanti M. P. Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem. 1996 Nov 15;271(46):29182–29190. doi: 10.1074/jbc.271.46.29182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Loscalzo J., Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis. 1995 Sep-Oct;38(2):87–104. doi: 10.1016/s0033-0620(05)80001-5. [DOI] [PubMed] [Google Scholar]
  20. Marletta M. A. Nitric oxide synthase: aspects concerning structure and catalysis. Cell. 1994 Sep 23;78(6):927–930. doi: 10.1016/0092-8674(94)90268-2. [DOI] [PubMed] [Google Scholar]
  21. Michel J. B., Feron O., Sacks D., Michel T. Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin. J Biol Chem. 1997 Jun 20;272(25):15583–15586. doi: 10.1074/jbc.272.25.15583. [DOI] [PubMed] [Google Scholar]
  22. Michel J. B., Feron O., Sase K., Prabhakar P., Michel T. Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. J Biol Chem. 1997 Oct 10;272(41):25907–25912. doi: 10.1074/jbc.272.41.25907. [DOI] [PubMed] [Google Scholar]
  23. Michel T., Li G. K., Busconi L. Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6252–6256. doi: 10.1073/pnas.90.13.6252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Milligan G., Parenti M., Magee A. I. The dynamic role of palmitoylation in signal transduction. Trends Biochem Sci. 1995 May;20(5):181–187. doi: 10.1016/s0968-0004(00)89004-0. [DOI] [PubMed] [Google Scholar]
  25. Moncada S., Higgs A., Furchgott R. International Union of Pharmacology Nomenclature in Nitric Oxide Research. Pharmacol Rev. 1997 Jun;49(2):137–142. [PubMed] [Google Scholar]
  26. Moncada S., Higgs E. A. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 1995 Oct;9(13):1319–1330. [PubMed] [Google Scholar]
  27. Nathan C., Xie Q. W. Nitric oxide synthases: roles, tolls, and controls. Cell. 1994 Sep 23;78(6):915–918. doi: 10.1016/0092-8674(94)90266-6. [DOI] [PubMed] [Google Scholar]
  28. Nathan C., Xie Q. W. Regulation of biosynthesis of nitric oxide. J Biol Chem. 1994 May 13;269(19):13725–13728. [PubMed] [Google Scholar]
  29. Pan J., Burgher K. L., Szczepanik A. M., Ringheim G. E. Tyrosine phosphorylation of inducible nitric oxide synthase: implications for potential post-translational regulation. Biochem J. 1996 Mar 15;314(Pt 3):889–894. doi: 10.1042/bj3140889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Parton R. G. Caveolae and caveolins. Curr Opin Cell Biol. 1996 Aug;8(4):542–548. doi: 10.1016/s0955-0674(96)80033-0. [DOI] [PubMed] [Google Scholar]
  31. Parton R. G., Joggerst B., Simons K. Regulated internalization of caveolae. J Cell Biol. 1994 Dec;127(5):1199–1215. doi: 10.1083/jcb.127.5.1199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Peng H. B., Libby P., Liao J. K. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem. 1995 Jun 9;270(23):14214–14219. doi: 10.1074/jbc.270.23.14214. [DOI] [PubMed] [Google Scholar]
  33. Peunova N., Enikolopov G. Amplification of calcium-induced gene transcription by nitric oxide in neuronal cells. Nature. 1993 Jul 29;364(6436):450–453. doi: 10.1038/364450a0. [DOI] [PubMed] [Google Scholar]
  34. Pollock J. S., Förstermann U., Mitchell J. A., Warner T. D., Schmidt H. H., Nakane M., Murad F. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10480–10484. doi: 10.1073/pnas.88.23.10480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Shaul P. W., Smart E. J., Robinson L. J., German Z., Yuhanna I. S., Ying Y., Anderson R. G., Michel T. Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem. 1996 Mar 15;271(11):6518–6522. doi: 10.1074/jbc.271.11.6518. [DOI] [PubMed] [Google Scholar]
  36. Shen W., Hintze T. H., Wolin M. S. Nitric oxide. An important signaling mechanism between vascular endothelium and parenchymal cells in the regulation of oxygen consumption. Circulation. 1995 Dec 15;92(12):3505–3512. doi: 10.1161/01.cir.92.12.3505. [DOI] [PubMed] [Google Scholar]
  37. Silvagno F., Xia H., Bredt D. S. Neuronal nitric-oxide synthase-mu, an alternatively spliced isoform expressed in differentiated skeletal muscle. J Biol Chem. 1996 May 10;271(19):11204–11208. doi: 10.1074/jbc.271.19.11204. [DOI] [PubMed] [Google Scholar]
  38. Stamler J. S. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell. 1994 Sep 23;78(6):931–936. doi: 10.1016/0092-8674(94)90269-0. [DOI] [PubMed] [Google Scholar]
  39. Stuehr D. J. Structure-function aspects in the nitric oxide synthases. Annu Rev Pharmacol Toxicol. 1997;37:339–359. doi: 10.1146/annurev.pharmtox.37.1.339. [DOI] [PubMed] [Google Scholar]
  40. Tamir S., deRojas-Walker T., Wishnok J. S., Tannenbaum S. R. DNA damage and genotoxicity by nitric oxide. Methods Enzymol. 1996;269:230–243. doi: 10.1016/s0076-6879(96)69025-9. [DOI] [PubMed] [Google Scholar]
  41. Venema V. J., Marrero M. B., Venema R. C. Bradykinin-stimulated protein tyrosine phosphorylation promotes endothelial nitric oxide synthase translocation to the cytoskeleton. Biochem Biophys Res Commun. 1996 Sep 24;226(3):703–710. doi: 10.1006/bbrc.1996.1417. [DOI] [PubMed] [Google Scholar]
  42. Vodovotz Y., Russell D., Xie Q. W., Bogdan C., Nathan C. Vesicle membrane association of nitric oxide synthase in primary mouse macrophages. J Immunol. 1995 Mar 15;154(6):2914–2925. [PubMed] [Google Scholar]
  43. Wedegaertner P. B., Wilson P. T., Bourne H. R. Lipid modifications of trimeric G proteins. J Biol Chem. 1995 Jan 13;270(2):503–506. doi: 10.1074/jbc.270.2.503. [DOI] [PubMed] [Google Scholar]
  44. Xia H., Bredt D. S. Cloned and expressed nitric oxide synthase proteins. Methods Enzymol. 1996;268:427–436. doi: 10.1016/s0076-6879(96)68045-8. [DOI] [PubMed] [Google Scholar]
  45. de Weerd W. F., Leeb-Lundberg L. M. Bradykinin sequesters B2 bradykinin receptors and the receptor-coupled Galpha subunits Galphaq and Galphai in caveolae in DDT1 MF-2 smooth muscle cells. J Biol Chem. 1997 Jul 11;272(28):17858–17866. doi: 10.1074/jbc.272.28.17858. [DOI] [PubMed] [Google Scholar]
  46. von der Leyen H. E., Gibbons G. H., Morishita R., Lewis N. P., Zhang L., Nakajima M., Kaneda Y., Cooke J. P., Dzau V. J. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1137–1141. doi: 10.1073/pnas.92.4.1137. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES